← Back to patent-cliff list
CAS 107-14-2
2-chloroacetonitrile2-Chloroacetonitrile
Codes: LINA-010, Tamsulosin Hydrochloride-106, BAZE-016, TREP-028
Application context (from source-drug indications)
Type 2 diabetesLinagliptinErectile dysfunctionTadalafil/TamsulosinBenign prostatic hyperplasiaTadalafil/TamsulosinLower urinary tract symptomsSolifenacin Succinate/Tamsulosin HydrochlorideBenign prostatic hyperplasiaSolifenacin Succinate/Tamsulosin HydrochlorideOveractive bladderSolifenacin Succinate/Tamsulosin HydrochlorideDrug-related adverse effects and reactionsSolifenacin Succinate/Tamsulosin HydrochlorideBladder neck obstructionSolifenacin Succinate/Tamsulosin HydrochlorideOestrogen deficiency syndromeConjugated Estrogens/Bazedoxifene AcetateOsteoporosisConjugated Estrogens/Bazedoxifene AcetateVasomotor symptomsConjugated Estrogens/Bazedoxifene AcetateNon-invasive ductal carcinomaConjugated Estrogens/Bazedoxifene AcetateAnxietyConjugated Estrogens/Bazedoxifene AcetateMenopausal symptomsConjugated Estrogens/Bazedoxifene AcetateBenign prostatic hyperplasiaDutasteride/Tamsulosin HydrochlorideBenign prostatic hyperplasiaTamsulosin HydrochlorideUrinary tract infectionTamsulosin HydrochlorideUrinary retentionTamsulosin HydrochlorideInguinal herniaTamsulosin HydrochlorideVoiding dysfunctionTamsulosin HydrochlorideLower urinary tract symptomsTamsulosin HydrochloridePostmenopausal osteoporosisBazedoxifene AcetateBreast cancerBazedoxifene AcetateOsteoporosisBazedoxifene AcetateMenopausal symptomsBazedoxifene AcetateInterstitial lung diseaseTreprostinilPulmonary hypertensionTreprostinilPulmonary arterial hypertensionTreprostinilIdiopathic pulmonary fibrosisTreprostinilPulmonary fibrosisTreprostinilIdiopathic pulmonary arterial hypertensionTreprostinil
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Linagliptin | Tier C — Watch / trade | 2029 |
| Tadalafil/Tamsulosin | Tier C — Watch / trade | - |
| Solifenacin Succinate/Tamsulosin Hydrochloride | Tier C — Watch / trade | - |
| Conjugated Estrogens/Bazedoxifene Acetate | Tier C — Watch / trade | - |
| Dutasteride/Tamsulosin Hydrochloride | Tier C — Watch / trade | - |
| Tamsulosin Hydrochloride | Tier C — Watch / trade | - |
| Bazedoxifene Acetate | Tier C — Watch / trade | - |
| Treprostinil | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione→2-(chloromethyl)-4-methylquinazoline→8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione→1-(2-aminophenyl)ethan-1-one→2-chloroacetonitrile→(R)-2-(piperidin-3-yl)isoindoline-1,3-dione (2S,3S)-2,3-dihydroxysuccinate→(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione→pyridin-3-amine→piperidin-3-amine→isobenzofuran-1,3-dione→2-(piperidin-3-yl)isoindoline-1,3-dione→(2S,3S)-2,3-dihydroxysuccinic acid
(4-Methoxyphenyl)acetic acid→1-(4-Methoxyphenyl)-2-propanone→Chloridosulfuric acid→2-Methoxy-5-(2-oxopropyl)benzene-1-sulfonyl chloride→1,1-Dimethylethylamine→N-tert-Butyl-2-methoxy-5-(2-oxopropyl)benzene-1-sulfonamide→(R)-(-)-1-Phenylethylamine→N-tert-Butyl-2-methoxy-5-[(2R)-2-[[(1R)-1-phenylethyl]amino]propyl]benzene-1-sulfonamide→5-[(2R)-2-Aminopropyl]-N-tert-butyl-2-methoxybenzene-1-sulfonamide→(2-Ethoxyphenoxy)acetonitrile→1-Hydroxy-2-ethoxybenzene→2-Chloroacetonitrile→N-tert-Butyl-5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzene-1-sulfonamide→(-)-5-[2(R)-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide
(4-Methoxyphenyl)acetic acid→1-(4-Methoxyphenyl)-2-propanone→Chloridosulfuric acid→2-Methoxy-5-(2-oxopropyl)benzene-1-sulfonyl chloride→1,1-Dimethylethylamine→N-tert-Butyl-2-methoxy-5-(2-oxopropyl)benzene-1-sulfonamide→(R)-(-)-1-Phenylethylamine→N-tert-Butyl-2-methoxy-5-[(2R)-2-[[(1R)-1-phenylethyl]amino]propyl]benzene-1-sulfonamide→5-[(2R)-2-Aminopropyl]-N-tert-butyl-2-methoxybenzene-1-sulfonamide→(2-Ethoxyphenoxy)acetonitrile→1-Hydroxy-2-ethoxybenzene→2-Chloroacetonitrile→N-tert-Butyl-5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzene-1-sulfonamide→(-)-5-[2(R)-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide
5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole→azepane→1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole→4-(hydroxymethyl)phenol→2-chloroacetonitrile→2-(4-(hydroxymethyl)phenoxy)acetonitrile→2-(4-(chloromethyl)phenoxy)acetonitrile→2-(4-((5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indol-1-yl)methyl)phenoxy)acetonitrile→2-(4-((5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indol-1-yl)methyl)phenoxy)acetic acid→1-(azepan-1-yl)-2-(4-((5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indol-1-yl)methyl)phenoxy)ethan-1-one→1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol
(4-Methoxyphenyl)acetic acid→1-(4-Methoxyphenyl)-2-propanone→Chloridosulfuric acid→2-Methoxy-5-(2-oxopropyl)benzene-1-sulfonyl chloride→1,1-Dimethylethylamine→N-tert-Butyl-2-methoxy-5-(2-oxopropyl)benzene-1-sulfonamide→(R)-(-)-1-Phenylethylamine→N-tert-Butyl-2-methoxy-5-[(2R)-2-[[(1R)-1-phenylethyl]amino]propyl]benzene-1-sulfonamide→5-[(2R)-2-Aminopropyl]-N-tert-butyl-2-methoxybenzene-1-sulfonamide→(2-Ethoxyphenoxy)acetonitrile→1-Hydroxy-2-ethoxybenzene→2-Chloroacetonitrile→N-tert-Butyl-5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzene-1-sulfonamide→(-)-5-[2(R)-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide
(4-Methoxyphenyl)acetic acid→1-(4-Methoxyphenyl)-2-propanone→Chloridosulfuric acid→2-Methoxy-5-(2-oxopropyl)benzene-1-sulfonyl chloride→1,1-Dimethylethylamine→N-tert-Butyl-2-methoxy-5-(2-oxopropyl)benzene-1-sulfonamide→(R)-(-)-1-Phenylethylamine→N-tert-Butyl-2-methoxy-5-[(2R)-2-[[(1R)-1-phenylethyl]amino]propyl]benzene-1-sulfonamide→5-[(2R)-2-Aminopropyl]-N-tert-butyl-2-methoxybenzene-1-sulfonamide→(2-Ethoxyphenoxy)acetonitrile→1-Hydroxy-2-ethoxybenzene→2-Chloroacetonitrile→N-tert-Butyl-5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzene-1-sulfonamide→(-)-5-[2(R)-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide
5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole→azepane→1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole→4-(hydroxymethyl)phenol→2-chloroacetonitrile→2-(4-(hydroxymethyl)phenoxy)acetonitrile→2-(4-(chloromethyl)phenoxy)acetonitrile→2-(4-((5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indol-1-yl)methyl)phenoxy)acetonitrile→2-(4-((5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indol-1-yl)methyl)phenoxy)acetic acid→1-(azepan-1-yl)-2-(4-((5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indol-1-yl)methyl)phenoxy)ethan-1-one→1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol
oct-2-yn-1-ol→(E)-oct-2-en-1-ol→((2R,3R)-3-pentyloxiran-2-yl)methanol→(S)-octane-1,3-diol→(S)-3-hydroxyoctyl 4-methylbenzenesulfonate→(S)-1-iodooctan-3-ol→2-(((S)-1-iodooctan-3-yl)oxy)tetrahydro-2H-pyran→dimethyl methylphosphonate→dimethyl ((4S)-4-((tetrahydro-2H-pyran-2-yl)oxy)nonyl)phosphonate→5-methoxy-3a,4-dihydronaphtho[2,3-b]furan-2(3H)-one→(9aS)-8-methoxy-3-((3S)-3-((tetrahydro-2H-pyran-2-yl)oxy)octyl)-1,4,9,9a-tetrahydro-2H-cyclopenta[b]naphthalen-2-one→(3aS,9aS)-5-methoxy-1-((3S)-3-((tetrahydro-2H-pyran-2-yl)oxy)octyl)-1,3,3a,4,9,9a-hexahydro-2H-cyclopenta[b]naphthalen-2-one→(1R,3aS,9aS)-5-methoxy-1-((3S)-3-((tetrahydro-2H-pyran-2-yl)oxy)octyl)-1,3,3a,4,9,9a-hexahydro-2H-cyclopenta[b]naphthalen-2-one→(1R,2R,3aS,9aS)-1-((S)-3-hydroxyoctyl)-5-methoxy-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-2-ol→(1R,2R,3aS,9aS)-1-((S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalene-2,5-diol→2-chloroacetonitrile→2-(((1R,2R,3aS,9aS)-2-hydroxy-1-((S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl)oxy)acetonitrile
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Taizhou GMP-like Site | 3-Methylxanthine Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | 8-Bromo-3-methyl-3,9-dihydro-1H-purine-2,6-dione Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 2-(Chloromethyl)-4-methylquinazoline Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | 8-Bromo-7-(but-2-yn-1-yl)-3-methy1-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | [(3R)-1-[7-(2-Butynyl)-2,3,6,7-tetrahydro-3-methy1-1-[(4-methy1-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yll-3-piperidinyllcarbamicacid 1,1-dimethylethyl ester Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | (1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]indene-2,5-diol Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | 1-broMo-5-fluoro-2-Methyl-3-nitrobenzene Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | methyl 4-cyclopropyl-2-fluorobenzoate Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | tert-butyl 2-(4-amino-6-chloropyrimidin-5-yloxy)ethylmethylcarbamate Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | 2H-Benz[f]inden-2-one, 9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3,3a,4,9-tetrahydro-5-methoxy-1-[(3S)-3-[(tetrahydro-2H-pyran-2-yl)oxy]octyl]-, (3aS,9R)- Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 2-allyl-3-methoxybenzaldehyde Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | (5S)-1-Decyn-5-ol Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.